Hormonal steroid contraceptives. 3. Adverse reactions.
D000328:Adult; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D001789:Blood Group Antigens; D001792:Blood Platelets / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D002170:Canada; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects* / Q000032:analysis; D003327:Coronary Disease / Q000139:chemically induced; D004967:Estrogens / Q000032:analysis; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005494:Folic Acid Deficiency / Q000139:chemically induced; D006801:Humans; D011183:Postoperative Complications / Q000139:chemically induced; D013923:Thromboembolism / Q000139:chemically induced / Q000453:epidemiology; D006113:United Kingdom; D014481:United States
D001789:Blood Group Antigens; D003276:Contraceptives, Oral; D004967:Estrogens